ZIGLIM PLUS (Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg))

Ziglim Plus 1 Tablet is a therapeutic formulation designed to assist in managing blood glucose levels. This medication is intended for individuals diagnosed with type 2 diabetes mellitus, and it is most effective when used in conjunction with a balanced diet and regular physical activity. The primary mechanism of action involves enhancing the utilization of insulin, which contributes to the reduction of blood sugar levels in the body. For optimal results, it is essential to adhere to the dosage and duration as prescribed by a healthcare professional. Taking this tablet with food is recommended to minimize the risk of gastrointestinal discomfort. In situations where a dose is missed, it is advised to take it promptly unless it is nearing the time for the subsequent dose; in which case, the missed dose should be skipped to maintain a consistent dosing schedule—doubling up on doses is not advised as it could lead to an overdose. Individuals on this medication should be vigilant about the potential for hypoglycemia, especially when combined with other antidiabetic agents, alcohol consumption, or erratic meal patterns. Regular monitoring of blood sugar levels is crucial while undergoing treatment. Potential side effects include gastrointestinal upset, headaches, and respiratory infections among others. It is important to disclose any pre-existing conditions such as kidney, liver, or heart issues to the prescribing healthcare provider. Pregnant or nursing women should seek medical advice prior to starting this medication, and healthcare providers may conduct kidney function assessments before treatment initiation. Limiting alcohol intake is advisable, as it may amplify the risk of adverse effects.